Rare case: concurrent Mycobacterium avium & M. kansasii infection in a patient w/ MDS & germline GATA2, on cobimetinib. Suggests profound susceptibility to NTM & therapeutic challenges in this setting. journals.sagepub.com/doi/10.1177/20…

📣 Special Collection — Call for Papers! 🧫🦠Share your insights on Combination Therapies for Complex Infections: synergy, resistance, PK/PD & precision use. 🧪 Deadline: Sept 15, 2025 Details at journals.sagepub.com/topic/collecti…

In CNS neuroimmunological disease, anti-CD20/S1PRM therapies blunt humoral responses even after 4th SARS-CoV-2 vaccine dose or breakthrough infection. Encouragingly, no evidence of intermediate-term neuroinflammation or neural injury post-COVID-19 journals.sagepub.com/doi/full/10.11…

ED study in Japan: Relaxation of COVID-19 IPC practices led to a surge in virus-related exacerbations of COPD (7.7%→52.5%) & asthma (39.7%→66.7%). Reinforcing viral prevention is key in chronic airway disease care. journals.sagepub.com/doi/full/10.11…

📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. Andrés Henao, MD, PhD journals.sagepub.com/topic/collecti…

What the DOTS trial of Staph bacteremia tells us: • Dalbavancin d1 and d8 vs daily IVs for WEEKS • No left-sided IE/CNS/prosthetics • Dalba not superior by DOOR endpoint, but similar clinical outcomes. Big implications for inpt care. More in link ⬇️⬇️⬇️

🆕💫 by 🌟s Todd C. Lee Emily McDonald CMI Communications Contextualizing the use of corticosteroids in severe Pneumocystis jirovecii pneumonia through a Bayesian lens #idxposts sciencedirect.com/science/articl…

🚨study from Bolivia: A novel PCR platform—Orange G3 TBC—shows comparable accuracy to GeneXpert Ultra for TB diagnosis (sensitivity = 90%, specificity = 97%). Its biosafe, low-resource–friendly design could expand TB testing access in endemic settings. journals.sagepub.com/doi/full/10.11…

🆕💫Systematic review of observational studies 7 cohort studies N= 1685 patients (305 cefazolin; 1380 ASPs) Comparative effectiveness of cefazolin Vs antistaphylococcal penicillins in MSSA IE PS: CloCeBa+ SNAP: not included in this SRMA #IEWiki journals.sagepub.com/doi/10.1177/20…

🆕💫Systematic review & meta-analysis 7 Retrospective studies N=1963 No single RCT! Efficacy & safety of echinocandins combined with Trimethoprim-Sulfa as first-line treatment for Pneumocystis pneumonia in HIV-infected & non-HIV-infected patients #IDXposts bmcinfectdis.biomedcentral.com/articles/10.11…

Glucocorticoid Dosing and Implications for Vaccination: Evolution of Global Definitions Clinical Infectious Diseases academic.oup.com/cid/article/80…

📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. Andrés Henao, MD, PhD journals.sagepub.com/topic/collecti…

Love to share our fruitful collaboration with our Peruvian scientists in the Amazon #GlobalHealth CU Anschutz Department of Medicine PCR–Confirmed Oropouche Virus Disease in Loreto, Perú: A Case Series From December 2023 Through September 2024 at Annals of Int Med acpjournals.org/doi/10.7326/AN…

🆕💫Systematic Review and Meta-Analysis of Observational Studies Oritavancin for Treatment of Osteomyelitis #IDXposts #OMWiki accpjournals.onlinelibrary.wiley.com/doi/10.1002/ph…

📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. Andrés Henao, MD, PhD journals.sagepub.com/topic/collecti…

The call for cases to participate in the IDWeek-ESCMID Fellows Exchange Program is open! 2 US-based fellows will be selected to participate in the Clinical Grand Rounds session at ESCMID 2026, April 17–21, in Munich, Germany. Submit your case by Dec. 17: abstractscorecard.com/cfp/submit/log…

Thrilled to have delivered the inaugural Sirus Naraqi, MD Memorial Lecture at @UICDomGrand Rounds this week! Topic: Chagas & NTDs – tackling health inequities in US immigrant communities. Huge thanks to my friend and colleague Max Brito for the invite! CU Anschutz Department of Medicine

🚨 FIRST first-author pub for Brent is OUT! “Insights into Current Coccidioidomycosis Therapeutic Pathways” now in ASM Fluconazole dominates, but switches are common in severe cases. Proud mentor moment! 🎉 CU Anschutz Department of Medicine journals.asm.org/doi/10.1128/aa…

📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. Andrés Henao, MD, PhD journals.sagepub.com/topic/collecti…

🆕⚡🍄📊 Cracking Coccidioidomycosis Pathways — Fluconazole First: Who Switches, Who Stays? | AAC 2025 🚀 What they did • Retrospective TriNetX cohort (2010–2024), 1,909 patients with coccidioidomycosis • Mapped real-world antifungal treatment pathways + switches • Compared